Understanding the relationship between PNPLA3, NAFLD and insulin resistance: Do ethnic differences bring more questions or more answers?

Liver International

Volumn 31, Issue 9, 2011, Pages 1246-1249

  Chang, Charissa Y ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ALLELE; DOWN REGULATION; EDITORIAL; ETHNIC DIFFERENCE; GENE; GENETIC ASSOCIATION; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; LOSS OF FUNCTION MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY; PNPLA3 GENE; PREVALENCE; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; LIPASE; LIVER; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC;

EID: 80052534977     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02612.x     Document Type: Editorial

References (19)

1. Das K, Das K, Mukherjee P, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010; 51: 1593-602.
2. Browning J, Szczepaniak L, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-95.
3. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-5.
4. Baulande S, Lasnier F, Lucas M, Pairault J. Adiponutrin, a transmembrane protein corresponding to a novel dietary and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 2001; 276: 33336-44.
5. He S, McPhaul C, Li J, et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 2010; 285: 6706-15.
6. Johannsen L, Hoffstedt J, Parikh H, et al. Variation in the adiponutrin gene influences its expression and associates with obesity. Diabetes 2006; 55: 826-33.
7. Sookoian S, Pirola C. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011; 53: 1883-94.
8. Hotta K, Yoneda M, Hyogo H, et al. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Medical Genetics 2010; 11: 1-10.
9. Kotronen A, Johansson LE, Johansson LM, et al. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 2009; 52: 1056-60.
10. Speliotes E, Butler J, Palmer C, et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010; 52: 904-12.
11. Chitturi S, Farrell G, Hashimoto E, et al. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-87.
12. Sookoian S, Castano GO, Burgueno AL, Gianotti TF, Rosselli MS, Pirola CJ. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 2009; 50: 2111-6.
13. Romeo S, Sentinelli F, Dash S, et al. Morbid obesity exposes the association between PNPLA3 I148M rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes (Lond) 2010; 34: 190-4.
14. Kantartzis K, Peter A, Machicao F, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patptin-like phospholipase 3 gene. Diabetes 2009; 58: 2616-23.
15. Rotman Y, Koh C, Zmuda J, et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52: 894-903.
16. Valenti L, Al-Serri A, Daly A, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1209-17.
17. Speliotes E, Yerges-Armstrong L, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genetics 2011; 7: 1-12.
18. Wang C, Lin H, Shin S, et al. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population. Liver Int 2011; 31: 1326-31.
19. Petit J, Guiu B, Masson D, et al. PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes. Liver Int 2011; 31: 1332-36.